Black Diamond Therapeutics, Inc. (BDTX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Black Diamond Therapeutics, Inc. (BDTX) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

BDTX Cash Flow Statement

Black Diamond Therapeutics, Inc. (BDTX) cash flow statement — 9-year operating, investing & financing cash flows

Annual Quarterly

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-7.14M	-10.23M	-6.79M	-7.85M	-9.16M	53.41M	-15.05M	-11.32M	-14.73M	-21.2M	-13.96M	-18.36M	-14.37M	-20.03M	-21.94M	-16.48M	-18.07M	-28.6M	-24.05M	-26.48M
Operating CF Margin %	-	-	-	-	-	76.3%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	22.01%	-119.16%	54.92%	30.67%	37.8%	351.95%	-7.87%	38.33%	-2.49%	-5.83%	36.39%	-11.45%	20.47%	29.96%	8.76%	37.78%	28.21%	-16.95%	-52.44%	-130.56%
Net Income	-9.9M	-9.04M	-15.12M	-8.5M	-10.56M	56.54M	-15.98M	-15.56M	-19.91M	-18.23M	-19.41M	-23.01M	-19.15M	-20.88M	-21.08M	-21.65M	-22.93M	-25.51M	-25.87M	-35.08M
Depreciation & Amortization	28K	27K	66K	86K	86K	87K	85K	86K	86K	86K	86K	115K	114K	122K	126K	807K	128K	125K	123K	43K
Stock-Based Compensation	1.51M	1.45M	1.41M	1.74M	1.78M	1.7M	1.64M	1.99M	5.29M	1.71M	1.54M	2.75M	2.65M	2.67M	2.91M	0	3.25M	3.38M	3.38M	3.01M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	-170K	0	0	0	0	0	0	0	0
Other Non-Cash Items	-2.66M	384K	7.84M	498K	344K	341K	25K	-320K	-406K	-204K	-95K	708K	719K	836K	770K	2.76M	821K	918K	1.05M	1.07M
Working Capital Changes	3.88M	-3.05M	-988K	-1.68M	-805K	-5.26M	-816K	2.48M	217K	-4.57M	3.92M	1.24M	1.3M	-2.79M	-4.66M	1.61M	662K	-7.51M	-2.73M	4.47M
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	-1.56M	2.39M	-396K	204K	-1.86M	-1.38M	2.04M	1.21M	-433K	-1.13M	1.63M	-1.86M	-343K	1.17M	-3.88M	3.54M	339K	-2.22M	-694K	628K
Cash from Investing	-3.12M	19.5M	-2.89M	8.59M	-59.15M	8.55M	27.77M	2.19M	740K	-13.73M	12.25M	-37.88M	17.18M	24.81M	2.32M	14.51M	19.81M	16.73M	43.24M	35.7M
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	0	-33K	0	0	0	8K	-193K	-7K	-333K	-1.49M
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	3K	1K	10K	0	0	0	38K	0	0	37.85K	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	71K	0	3K	13K	8K	48K	0	0	0	-37.85K	95K	0	9K	0	0	0	0	0
Cash from Financing	217K	-185K	-196K	134K	-116K	32K	291K	-252K	21.38M	4.13M	-46K	71.93M	0	51K	-28K	52K	0	153K	0	64K
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	0	0	-196K	134K	-116K	32K	0	-500K	21.01M	3.98M	0	71.85M	0	0	0	52K	0	0	0	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	217K	-185K	0	0	0	0	291K	248K	364K	150K	-46K	77K	0	51K	-28K	0	0	153K	0	64K
Net Change in Cash	-10.05M	9.08M	-9.87M	874K	-68.43M	61.99M	13.01M	-9.38M	7.39M	-30.8M	-1.75M	15.68M	2.81M	4.83M	-19.64M	-1.92M	1.74M	-11.72M	19.2M	9.28M
Free Cash Flow	-7.14M	-10.23M	-6.79M	-7.85M	-9.16M	53.41M	-15.05M	-11.32M	0	-21.2M	-13.96M	-18.39M	-14.37M	-20.03M	-21.94M	-16.47M	-18.26M	-28.61M	-24.38M	-27.97M
FCF Margin %	-	-	-	-	-	76.3%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	22.01%	-119.16%	54.92%	30.67%	-	351.95%	-7.87%	38.45%	100%	-5.83%	36.39%	-11.7%	21.31%	29.98%	10.01%	41.12%	29.8%	-16.79%	-53.49%	-143.35%
FCF per Share	-0.12	-0.18	-0.12	-0.14	-0.16	0.93	-0.27	-0.20	-	-0.41	-0.29	-0.36	-0.39	-0.55	-0.60	-0.45	-0.50	-0.79	-0.67	-0.77
FCF Conversion (FCF/Net Income)	0.72x	1.13x	0.45x	0.92x	0.87x	0.94x	0.94x	0.73x	0.74x	1.16x	0.72x	0.80x	0.75x	0.96x	1.04x	0.76x	0.79x	1.12x	0.93x	0.75x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0